Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnerships
Biotech
Takeda drops AZ-partnered neurological program after ph. 2 fail
Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study.
James Waldron
Oct 30, 2025 9:25am
NewAmsterdam partners with AI-based Caristo Diagnostics
Oct 15, 2025 9:30am
Turbine looks to turbocharge AstraZeneca's ADC discovery
Oct 9, 2025 6:00am
Alpenglow teams up with Virdx to boost prostate cancer diagnosis
Oct 8, 2025 9:20am
BioLineRx forges joint cancer venture with Norwegian biotech
Sep 29, 2025 11:22am
Philips, Masimo re-up patient monitor partnership with AI focus
Sep 12, 2025 12:00pm
